MedPath

Interest of Animal-assisted Therapy With Dogs in the Treatment of Depression

Not Applicable
Not yet recruiting
Conditions
Depression
Registration Number
NCT06449690
Lead Sponsor
Fondation Bon Sauveur De La Manche
Brief Summary

This study is a randomized controlled trial (comparing "occupational activities" versus "dog-assisted therapy" arms) investigating the effectiveness of animal-assisted therapy with dogs in small groups of participants with depression. Patients in the "dog-assisted therapy" arm will participate in two group sessions (groups of 3 to 7 participants) of canine-assisted therapy, supervised by a healthcare professional certified in animal-assisted therapy alongside a psychiatric caregiver, for 30 minutes each week over 6 weeks. Patients in the "occupational activities" arm will participate in two group sessions (groups of 3 to 7 participants) of occupational activities, supervised by a healthcare professional experienced in group occupational activities alongside a psychiatric caregiver, for 30 minutes each week over 6 weeks.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
58
Inclusion Criteria
  • Patient aged 18 to 65
  • Patient affiliated with a social security scheme
  • Patient hospitalized under voluntary psychiatric care
  • Diagnosis of depression according to DSM-5-TR criteria
  • QIDS-C16 score ≥11 at screening
  • QIDS-SR16 score ≥11 at screening and inclusion
Exclusion Criteria
  • Severe comorbid psychiatric disorder
  • Imminent risk of suicidal behavior
  • Unstable comorbid somatic condition
  • Vulnerable patients (under guardianship, curatorship, or judicial protection)
  • Known fear of dogs
  • Known allergy to dog fur

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Change in the 17-item Hamilton Depression Rating Scale (HDRS) score from baseline to 6 weeks.Baseline and week 6

The 17-item Hamilton Depression Rating Scale (HDRS) is a validated scale for depression assessment, its score is rated between 0 and 52 and a higher score means a more depressed state

Secondary Outcome Measures
NameTimeMethod
Evolution of the 17-item Hamilton scale score between 0 and 3 weeks.Baseline and week 3

The 17-item Hamilton Depression Rating Scale (HDRS) is a validated scale for depression assessment, its score is rated between 0 and 52 and a higher score means a more depressed state

Evolution of the quality of life scale score (WHOQOL-BREF) at 3 and 6 weeks, compared to the initial score at W0.Baseline and weeks 3 and 6

The World Health Organization Quality Of Life (WHOQOL) WHOQOL-BREF scale is a validated scale for the measurement of quality of life, its score is rated between 0 and 100 and a higher score means better quality of life

Evaluation of the number of adverse events and serious adverse events related to the therapy under study.From baseline up to 6 weeks

The number of AEs will be used to assess the safety of the therapy.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.